栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/12/16 | 2,030 | 2,055 | 2,016 | 2,034 | +13 | +0.6% | 127,100 |
2020/12/15 | 2,023 | 2,053 | 2,014 | 2,021 | +7 | +0.3% | 155,000 |
2020/12/14 | 2,031 | 2,051 | 2,011 | 2,014 | -20 | -1% | 168,500 |
2020/12/11 | 1,978 | 2,041 | 1,978 | 2,034 | +64 | +3.2% | 259,800 |
2020/12/10 | 1,978 | 1,979 | 1,949 | 1,970 | ±0 | ±0% | 93,000 |
2020/12/09 | 1,958 | 1,975 | 1,952 | 1,970 | +25 | +1.3% | 106,400 |
2020/12/08 | 1,950 | 1,959 | 1,936 | 1,945 | -16 | -0.8% | 86,800 |
2020/12/07 | 1,999 | 2,000 | 1,953 | 1,961 | -38 | -1.9% | 131,700 |
2020/12/04 | 1,988 | 2,026 | 1,985 | 1,999 | +14 | +0.7% | 229,100 |
2020/12/03 | 1,960 | 2,010 | 1,956 | 1,985 | +29 | +1.5% | 234,900 |
2020/12/02 | 1,943 | 1,981 | 1,935 | 1,956 | +13 | +0.7% | 213,000 |
2020/12/01 | 1,935 | 1,961 | 1,925 | 1,943 | +6 | +0.3% | 103,600 |
2020/11/30 | 1,961 | 1,971 | 1,936 | 1,937 | -27 | -1.4% | 138,900 |
2020/11/27 | 1,964 | 1,988 | 1,946 | 1,964 | +9 | +0.5% | 232,700 |
2020/11/26 | 1,925 | 1,964 | 1,904 | 1,955 | +27 | +1.4% | 177,500 |
2020/11/25 | 1,955 | 1,973 | 1,928 | 1,928 | -14 | -0.7% | 212,700 |
2020/11/24 | 2,003 | 2,024 | 1,942 | 1,942 | -25 | -1.3% | 400,700 |
2020/11/20 | 1,982 | 2,044 | 1,917 | 1,967 | +137 | +7.5% | 831,000 |
2020/11/19 | 1,840 | 1,862 | 1,812 | 1,830 | -30 | -1.6% | 202,000 |
2020/11/18 | 1,891 | 1,901 | 1,857 | 1,860 | -31 | -1.6% | 145,400 |
2020/11/17 | 1,959 | 1,959 | 1,889 | 1,891 | -49 | -2.5% | 201,400 |
2020/11/16 | 1,950 | 1,981 | 1,939 | 1,940 | +1 | +0.1% | 194,100 |
2020/11/13 | 1,962 | 1,962 | 1,914 | 1,939 | -23 | -1.2% | 152,700 |
2020/11/12 | 2,000 | 2,003 | 1,944 | 1,962 | -29 | -1.5% | 245,000 |
2020/11/11 | 2,029 | 2,029 | 1,982 | 1,991 | -3 | -0.2% | 183,700 |
2020/11/10 | 2,098 | 2,098 | 1,992 | 1,994 | -73 | -3.5% | 258,600 |
2020/11/09 | 2,071 | 2,075 | 2,053 | 2,067 | +34 | +1.7% | 130,600 |
2020/11/06 | 2,046 | 2,051 | 2,029 | 2,033 | -13 | -0.6% | 125,000 |
2020/11/05 | 2,039 | 2,056 | 2,018 | 2,046 | +24 | +1.2% | 206,800 |
2020/11/04 | 2,021 | 2,031 | 1,985 | 2,022 | +8 | +0.4% | 182,200 |
2020/11/02 | 2,011 | 2,050 | 2,004 | 2,014 | +20 | +1% | 250,300 |
2020/10/30 | 2,065 | 2,076 | 1,985 | 1,994 | -64 | -3.1% | 216,900 |
2020/10/29 | 2,066 | 2,070 | 2,042 | 2,058 | -41 | -2% | 223,000 |
2020/10/28 | 2,098 | 2,120 | 2,079 | 2,099 | +2 | +0.1% | 292,800 |
2020/10/27 | 2,150 | 2,150 | 2,027 | 2,097 | -130 | -5.8% | 725,500 |
2020/10/26 | 2,215 | 2,238 | 2,202 | 2,227 | +32 | +1.5% | 204,100 |
2020/10/23 | 2,189 | 2,199 | 2,166 | 2,195 | +2 | +0.1% | 162,000 |
2020/10/22 | 2,233 | 2,233 | 2,174 | 2,193 | -71 | -3.1% | 224,600 |
2020/10/21 | 2,230 | 2,287 | 2,229 | 2,264 | +7 | +0.3% | 238,100 |
2020/10/20 | 2,282 | 2,282 | 2,253 | 2,257 | -23 | -1% | 137,700 |
2020/10/19 | 2,286 | 2,297 | 2,267 | 2,280 | -3 | -0.1% | 148,900 |
2020/10/16 | 2,297 | 2,303 | 2,267 | 2,283 | -14 | -0.6% | 168,700 |
2020/10/15 | 2,332 | 2,332 | 2,281 | 2,297 | -46 | -2% | 253,800 |
2020/10/14 | 2,362 | 2,390 | 2,323 | 2,343 | -33 | -1.4% | 296,400 |
2020/10/13 | 2,398 | 2,406 | 2,372 | 2,376 | -22 | -0.9% | 178,000 |
2020/10/12 | 2,394 | 2,407 | 2,388 | 2,398 | +28 | +1.2% | 197,200 |
2020/10/09 | 2,352 | 2,377 | 2,334 | 2,370 | +33 | +1.4% | 294,600 |
2020/10/08 | 2,279 | 2,337 | 2,267 | 2,337 | +58 | +2.5% | 318,200 |
2020/10/07 | 2,271 | 2,295 | 2,266 | 2,279 | +8 | +0.4% | 197,000 |
2020/10/06 | 2,269 | 2,281 | 2,246 | 2,271 | +1 | ±0% | 212,100 |
951~
1000
件表示中 / 6826件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 232,200円 | +0.4% | -8.4% | 2.28% | 30.69倍 | 1.75倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 121,300円 | +197.7% | - | 0.00% | 49.57倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 67,900円 | -3.7% | -36.7% | 2.95% | 23.03倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 101,300円 | - | - | 0.00% | - | 51.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム